The selective metabotropic glutamate 2/3 receptor agonist MGS0028 reverses psychomotor abnormalities and recognition memory deficits in mice lacking the pituitary adenylate cyclase-activating polypeptide

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Behavioural Pharmacology

• Publication date

  2013-02-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1097/FBP.0b013e32835cf3e5PMID 23268987
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serotonin 5-HT7 Receptor Blockade Reverses Behavioral Abnormalities in PACAP-Deficient Mice and Receptor Activation Promotes Neurite Extension in Primary Embryonic Hippocampal Neurons

  2012cited by this paper
• Serotonin 5-HT(7) receptor blockade reverses behavioral abnormalities in PACAP-deficient mice and receptor activation promotes neurite extension in primary embryonic hippocampal neurons: therapeutic implications for psychiatric disorders.

  2012cited by this paper
• The selective metabotropic glutamate 2/3 receptor agonist MGS0028 reverses isolation rearing-induced abnormal behaviors in mice.

  2012cited by this paper
• A Multicenter, Inpatient, Phase 2, Double-Blind, Placebo-Controlled Dose-Ranging Study of LY2140023 Monohydrate in Patients With DSM-IV Schizophrenia

  2011cited by this paper
• Attention deficit induced by blockade of N-methyl D-aspartate receptors in the prefrontal cortex is associated with enhanced glutamate release and cAMP response element binding protein phosphorylation: role of metabotropic glutamate receptors 2/3.

  2011cited by this paper
• Interaction of mGlu2/3 agonism with clozapine and lurasidone to restore novel object recognition in subchronic phencyclidine-treated rats

  2011cited by this paper
• Possible association between the pituitary adenylate cyclase-activating polypeptide (PACAP) gene and major depressive disorder.

  2010cited by this paper
• Environmental factors during early developmental period influence psychobehavioral abnormalities in adult PACAP-deficient mice.

  2010influential reference
• Group II metabotropic glutamate receptor agonists as a potential drug for schizophrenia.

  2010cited by this paper
• The mGluR2/3 agonist LY379268 reverses post-weaning social isolation-induced recognition memory deficits in the rat

  2010cited by this paper
• Depression‐like behavior in the forced swimming test in PACAP‐deficient mice: amelioration by the atypical antipsychotic risperidone

  2009cited by this paper
• Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery

  2009cited by this paper
• Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

  2007cited by this paper
• Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia

  2007cited by this paper
• Psychostimulant-Induced Attenuation of Hyperactivity and Prepulse Inhibition Deficits in Adcyap1-Deficient Mice

  2006influential reference
• A Selective Allosteric Potentiator of Metabotropic Glutamate (mGlu) 2 Receptors Has Effects Similar to an Orthosteric mGlu2/3 Receptor Agonist in Mouse Models Predictive of Antipsychotic Activity

  2005cited by this paper
• Molecular pharmacology and therapeutic prospects of metabotropic glutamate receptor allosteric modulators.

  2005influential reference
• Metabotropic glutamate 2 receptor potentiators: receptor modulation, frequency-dependent synaptic activity, and efficacy in preclinical anxiety and psychosis model(s)

  2005cited by this paper
• Altered psychomotor behaviors in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP)

  2001influential reference
• Synthesis, SARs, and pharmacological characterization of 2-amino-3 or 6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives as potent, selective, and orally active group II metabotropic glutamate receptor agonists.

  2000influential reference

• Activation of the PACAP/PAC1 Signaling Pathway Accelerates the Repair of Impaired Spatial Memory Caused by an Ultradian Light Cycle

  2023cites this paper
• Small-molecule non-peptide antagonists of the PACAP receptor attenuate acute restraint stress-induced anxiety-like behaviors in mice.

  2022cites this paper
• Inhibition of PACAP/PAC1/VPAC2 signaling impairs the consolidation of social recognition memory and nitric oxide prevents this deficit.

  2021cites this paper
• The role of pituitary adenylyl cyclase activating polypeptide in affective signs of nicotine withdrawal

  2020cites this paper
• The role of pituitary adenylyl cyclase-activating polypeptide in the motivational effects of addictive drugs.

  2020cites this paper
• Effects of PACAP-38 and an analog, acetyl-[Ala15, Ala20] PACAP-38-propylamide, on memory consolidation in the detection of spatial novelty task in rats.

  2020cites this paper
• P.186 Molecular pathways underlying schizophrenia

  2020cites this paper
• Molecular signaling pathways underlying schizophrenia

  2020cites this paper
• Pituitary Adenylate Cyclase-Activating Polypeptide Modulates Dendritic Spine Maturation and Morphogenesis via MicroRNA-132 Upregulation

  2019cites this paper
• Emerging evidence for the role of pituitary adenylate cyclase-activating peptide in neuropsychiatric disorders.

  2019cites this paper
• Pituitary Adenylate Cyclase-Activating Polypeptide Modulates Hippocampal Synaptic Transmission and Plasticity: New Therapeutic Suggestions for Fragile X Syndrome

  2019cites this paper
• The Use of Object Recognition Task in Animal Models of Attention-Deficit Hyperactivity Disorder

  2018cites this paper
• Novel Roles of Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) and its Receptors in Social Behaviors and Stress Responses in the Mouse

  2016cites this paper
• Critical involvement of the orbitofrontal cortex in hyperlocomotion induced by NMDA receptor blockade in mice.

  2016cites this paper
• Methamphetamine-Induced Hyperlocomotion

  2016cites this paper
• The Emerging Role of Metabotropic Glutamate Receptors in the Pathophysiology of Chronic Stress-Related Disorders

  2016cites this paper
• PACAP and Neural Development

  2016cites this paper
• Implications of PACAP Signaling in Psychiatric Disorders

  2016cites this paper
• Atomoxetine reverses locomotor hyperactivity, impaired novel object recognition, and prepulse inhibition impairment in mice lacking pituitary adenylate cyclase-activating polypeptide.

  2015cites this paper
• Ligation of metabotropic glutamate receptor 3 (Grm3) ameliorates lupus-like disease by reducing B cells.

  2015cites this paper
• Pituitary Adenylate Cyclase Activating Polypeptide in Stress-Related Disorders: Data Convergence from Animal and Human Studies

  2015cites this paper
• Involvement of prefrontal AMPA receptors in encounter stimulation-induced hyperactivity in isolation-reared mice.

  2014influential citation
• Increased Behavioral and Neuronal Responses to a Hallucinogenic Drug in PACAP Heterozygous Mutant Mice

  2014cites this paper
• Behavioral characterization of mice overexpressing human dysbindin-1

  2014cites this paper
• An enriched environment ameliorates memory impairments in PACAP-deficient mice.

  2014cites this paper
• Cognitive Enhancers (Nootropics). Part 1: Drugs interacting with Receptors. Update 2014

  2014cites this paper
• PACAP and PAC1 receptor in brain development and behavior.

  2013cites this paper
• Stimulation of metabotropic glutamate (mGlu) 2 receptor and blockade of mGlu1 receptor improve social memory impairment elicited by MK-801 in rats.

  2013cites this paper
• Neuropharmacologic studies on the brain serotonin1A receptor using the selective agonist osemozotan.

  2013cites this paper
• Neuropeptides in learning and memory.

  2013cites this paper